RxDoctor Payments Data

Joseph Pool, MD

Internal Medicine · Hilliard, OHNPI 1659336287

Payments from drug & device makers

$232in general payments, 2019–2025

Across 13 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$91
  • Novo Nordisk$52
  • Exact Sciences$35
  • Abbott$15
  • Amgen$15
  • Merck$13
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$232100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)5$91
Novo Nordisk3$52
Exact Sciences1$35
Abbott1$15
Amgen1$15
Merck1$13
Pfizer1$11

How this compares

$232 in reported general payments places this provider in the 50th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$146,244
Medicare patients
267
Services billed
7,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban146$151,067
TrulicityDulaglutide45$56,381
OzempicSemaglutide28$49,147
JanuviaSitagliptin Phosphate44$48,526
JardianceEmpagliflozin30$39,101
XareltoRivaroxaban35$38,031
FarxigaDapagliflozin Propanediol17$13,191
LinzessLinaclotide13$12,458
Breo ElliptaFluticasone/Vilanterol25$9,748
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$8,814
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,409
JanumetSitagliptin Phos/Metformin Hcl12$6,495
Advair HfaFluticasone Propion/Salmeterol16$5,872
Atorvastatin Calcium725$5,737
ShingrixVaricella-Zoster Ge/As01b/Pf22$4,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$11$153,909176 claims
MerckJanuvia, Janumet$13$55,02056 claims
Novo NordiskOzempic$52$49,14728 claims
AbbVieLinzess, Synthroid$91$15,28669 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Hilliard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →